Nav: Home

Mitochondrial DNA levels in the blood may predict risk of developing kidney disease

January 21, 2016

Washington, DC (January 21, 2016) -- The health of blood cells' energy-producing mitochondria may predict a person's risk of developing chronic kidney disease (CKD), according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings could lead to improvements in the prevention and treatment of CKD.

In the United States, approximately 26 million people, or 13% of US adults, have CKD. While there are a variety of causes of CKD, many cases involve dysfunction of kidney cells' mitochondria, or the cellular components that produce energy that's critical for cells to survive.

To investigate whether the number of copies of mitochondrial genes (mitochondria DNA copy number) in blood might be a marker of CKD risk, Adrienne Tin, PhD (Johns Hopkins Bloomberg School of Public Health) and her colleagues analyzed data from 9058 participants of the Atherosclerosis Risk in Communities (ARIC) Study, a prospective epidemiologic study conducted in 4 US communities.

Over a median follow-up of 19.6 years, the researchers found that higher levels of mitochondrial DNA copy number were linked with a lower risk of developing CKD. After adjusting for various factors including age, sex, race, diabetes, and hypertension, individuals with the highest levels of mitochondrial DNA copy number had a 25% lower risk of developing CKD compared with individuals with the lowest levels.

"This result suggests modifiable factors influencing mitochondrial DNA copy number may be potential targets for the prevention and treatment of CKD," said Dr. Tin.
Study co-authors include Morgan Grams, MD, PhD; Foram Ashar, BS; John Lan, BS; Avi Rosenberg, MD, PhD; Megan Grove, PhD; Eric Boerwinkle, PhD; Elizabeth Selvin, PhD; Josef Coresh, MD, PhD; Nathan Pankratz, PhD; and Dan Arking, PhD.

Disclosures: The authors reported no financial disclosures.

The article, entitled "Association between Mitochondrial DNA Copy Number in Peripheral Blood and Incident Chronic Kidney Disease: Results from the Atherosclerosis Risk in Communities (ARIC) Study," will appear online at on January 21, 2016, doi: 10.1681/ASN.2015060661.

The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.

Founded in 1966, and with nearly 16,000 members, the American Society of Nephrology (ASN) leads the fight against kidney disease by educating health professionals, sharing new knowledge, advancing research, and advocating the highest quality care for patients.

American Society of Nephrology

Related Mitochondria Articles:

Mitochondria-targeted antioxidant SkQ1 helps to treat diabetic wounds
Members of the Faculty of Biology and A.N. Belozersky Institute of Physico-Chemical Biology, a unit of the Lomonosov Moscow State University, have tested on a mouse model a mitochondria-targeted antioxidant, helping to treat diabetic wounds.
Mitochondria targeting anti-tumor compound
Researchers from Kumamoto University in Japan have found that the compound folic acid-conjugated methyl-BETA-cyclodextrin (FA-M-BETA-CyD) has significant antitumor effects on folate receptor-ALPHA-expressing (FR-ALPHA (+)) cancer cells.
Closing the gate to mitochondria
A team of researchers develops a new method that enables the identification of proteins imported into mitochondria.
Elucidated connection between renal failure and 'bad' mitochondria described
Biologists from the A.N. Belozersky Institute of Physico-Chemical Biology, a unit of the Lomonosov Moscow State University suggested the approach to prevent kidney injury after ischemia.
How exercise -- interval training in particular -- helps your mitochondria stave off old age
Researchers have long suspected that the benefits of exercise extend down to the cellular level, but know relatively little about which exercises help cells rebuild key organelles that deteriorate with aging.
More Mitochondria News and Mitochondria Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#534 Bacteria are Coming for Your OJ
What makes breakfast, breakfast? Well, according to every movie and TV show we've ever seen, a big glass of orange juice is basically required. But our morning grapefruit might be in danger. Why? Citrus greening, a bacteria carried by a bug, has infected 90% of the citrus groves in Florida. It's coming for your OJ. We'll talk with University of Maryland plant virologist Anne Simon about ways to stop the citrus killer, and with science writer and journalist Maryn McKenna about why throwing antibiotics at the problem is probably not the solution. Related links: A Review of the Citrus Greening...